abacavir and Obesity--Morbid

abacavir has been researched along with Obesity--Morbid* in 1 studies

Other Studies

1 other study(ies) available for abacavir and Obesity--Morbid

ArticleYear
Case Report of Increased Exposure to Antiretrovirals following Sleeve Gastrectomy.
    Antimicrobial agents and chemotherapy, 2020, 03-24, Volume: 64, Issue:4

    Bariatric surgery is increasingly performed in morbidly obese HIV patients. Limited data exist regarding antiretroviral drug exposure after bariatric surgery. We report a case of a morbidly obese HIV patient who underwent sleeve gastrectomy. Abacavir, lamivudine, and dolutegravir therapeutic drug monitoring was performed at several time points pre- and postsurgery. Significantly increased levels were measured, particularly for abacavir, whose levels increased ∼12-fold. Several mechanistic explanations for these findings are discussed.

    Topics: Adult; Anti-Retroviral Agents; Bariatric Surgery; Dideoxynucleosides; Drug Monitoring; Gastrectomy; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Male; Obesity, Morbid; Oxazines; Piperazines; Pyridones

2020